India, Sept. 22 -- The following biotech stocks reached a 52-week high on September 22, 2026, driven by key catalysts such as positive quarterly reports or results from clinical trials.
Amneal Pharmaceuticals Inc. (AMRX)
Amneal Pharmaceuticals is a biopharmaceutical company that develops and manufactures generic drugs and biosimilar medications.
Shares rose over 7% to a 52-week high of $21.17 on Monday.
The company received approval from the U.S. Food and Drug Administration (FDA) last week for its generic Lanreotide injection, a biosimilar of Ipsen's SOMATULINE, used to treat acromegaly, neuroendocrine tumors, and carcinoid syndrome.
In August, Amneal completed the acquisition of Kashiv BioSciences LLC, a biologics company, to facilit...